Evidence map›Paper›PMID 38094603›Full record

ArticleFrontiers in oncology2023

Colorectal cancer survival among Malaysia population: data from the Malaysian National Cancer Registry.

Nor Asiah Muhamad, Nur Hasnah Ma'amor, Izzah Athirah Rosli, Fatin Norhasny Leman, Mohd Hatta Abdul Mutalip, Huan-Keat Chan, Siti Norbayah Yusof, Nor Saleha Ibrahim Tamin, Tahir Aris, Nai Ming Lai and 1 more

Abstract read
In one paragraph

Article in Frontiers in oncology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Article
  4. Review
  5. Article
  6. Colorectal Neoplasia in Vietnamese Patients Under 50 Years of Age: A Cross-Sectional Study.The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi · 2025
    Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Nor Asiah MuhamadSector for Evidence-based Healthcare, National Institutes of Health, Ministry of Health, Setia Alam, Malaysia.
Nur Hasnah Ma'amorSector for Evidence-based Healthcare, National Institutes of Health, Ministry of Health, Setia Alam, Malaysia.
Izzah Athirah RosliSector for Evidence-based Healthcare, National Institutes of Health, Ministry of Health, Setia Alam, Malaysia.
Fatin Norhasny LemanSector for Evidence-based Healthcare, National Institutes of Health, Ministry of Health, Setia Alam, Malaysia.
Mohd Hatta Abdul MutalipCentre for Communicable Diseases Research, Institutes for Public Health, National Institute of Health, Ministry of Health, Setia Alam, Malaysia.
Huan-Keat ChanClinical Research Centre, Sultanah Bahiyah Hospital, Ministry of Health, Alor Setar, Malaysia.
Siti Norbayah YusofNational Cancer Institute, Ministry of Health, Putrajaya, Malaysia.
Nor Saleha Ibrahim TaminCancer Prevention and Control Unit, Non-communicable Disease Division, Ministry of Health, Putrajaya, Malaysia.
Tahir ArisInstitute for Medical Research, National Institutes of Health, Ministry of Health, Setia Alam, Malaysia.
Nai Ming LaiSchool of Medicine, Taylor's University, Subang Jaya, Malaysia.
Muhammad Radzi Abu HassanClinical Research Centre, Sultanah Bahiyah Hospital, Ministry of Health, Alor Setar, Malaysia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Colorectal cancer (CRC) is a major cause of cancer-related mortality worldwide. It is the second leading cause of cancer death in men and women in Malaysia and poses a major burden on society. Aims: To determine the overall survival rate of patients diagnosed with CRC and factors contributing to survival. Methods: Data were obtained from the Malaysia National Cancer Registry. All patients with CRC were identified, and a total of 15,515 patients were screened. A total of 5,675 CRC patients were included from January 1, 2012, to December 31, 2016. Sex, age groups, ethnic groups, stage at diagnosis, cancer sites, and status of treatment received were analysed. The Kaplan-Meier analysis was performed to estimate the 1-, 3-, and 5-year survival of CRC. The log-rank test was conducted to compare the survival between sex, age groups, ethnic groups, stage at diagnosis, cancer sites, and status of treatment received. Multiple Cox regression was conducted to determine the risk of CRC death. Results: Of 5,675, a total of 2,055 had died, 3,534 were censored, and another 86 were still alive within 5 years of CRC diagnosis. The 1-, 3-, and 5-year survival rates were 68.5%, 34.7%, and 18.4%, respectively with a median survival time of 24 months. Significant differences in survival rates of CRC were observed between age groups ( Conclusion: In general, Malaysian patients with CRC had low survival rates. National health policies should focus on enhancing awareness of CRC, encouraging early screening, and developing strategies for early detection and management to reduce CRC-associated mortality.

Indexed as

colorectal neoplasmcumulative survivalhazardMalaysiasurvival time

Identifiers

PMID38094603
PMCPMC10718645

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.